Gallery
PM Modi visit USA
Only the mirror in my washroom and phone gallery see the crazy me : Sara Khan
Karnataka rain fury: Photos of flooded streets, uprooted trees
Cannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfit
Ranbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A Kiss
Oscars 2022: Every Academy Award Winner
Shane Warne (1969-2022): Australian cricket legend's life in pictures
Photos: What Russia's invasion of Ukraine looks like on the ground
Lata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'
PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
Moderna to make up to 125 million Covid vaccine doses available globally Last Updated : 04 Dec 2020 08:42:11 PM IST 
Moderna US-based drugmaker Moderna has said that it expects to have between 100 million and 125 million doses of its experimental vaccine ' title=' Covid vaccine '>Covid vaccine available globally in the first quarter of 2021.
Out of these, about 85-100 million doses will be made available in the US and 15-25 million doses will be available outside of the US, the company said on Thursday.These expected first quarter doses are inclusive within the 500 million to up to one billion doses that the company expects to manufacture globally in 2021.Moderna also re-affirmed its expectation of having approximately 20 million doses available in the US by the end of this year.The development comes after the company's November 30 announcement that the primary efficacy analysis of the Phase 3 study of the "mRNA-1273" vaccine showed efficacy of 94.1 per cent.Also on November 30, Moderna submitted a request for an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA).Apart from Moderna, drug makers Pfizer and BioNTech also applied for emergency authorisation of their Covid-19 vaccine from the US FDA.Britain on Wednesday approved the emergency use of the Pfizer-BioNTech Covid-19 vaccine from next week.IANS New York For Latest Updates Please-
Join us on
Follow us on
What binds the two most talked about nations - India and Pakistan together? What makes the
Raipur-based lawyer Faizan Khan – who was arrested in connection with the extortion-cum-
LG Electronics Inc said on Wednesday that it will introduce new C with its artificial inte
172.31.16.186
